by The Global cervical cancer diagnostic market size is expected to reach around US$ 22 billion by 2030 and is anticipated to grow at a CAGR of 15.9% during forecast period 2021 to 2030.
Recently Published Report on “cervical cancer diagnostic Market – Global Industry Analysis, Market Size, Share, Growth, Trends, Region Outlook, And Segment Forecasts, 2021 – 2030”.
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38054
Report Highlights
Pap test held a majority share of 49.6% of the segment in 2020. Pap test helps diagnose abnormal cells of the cervix that may potentially develop into cancer at a later stage. This test accounts for the largest share on account of the high efficiency of this test. Furthermore, the increasing awareness regarding early diagnosis contributes to the growth of this segment.
HPV testing is expected to grow at a lucrative CAGR of 15.3% due to the upsurge in the demand for technologically advanced diagnostics procedures at low costs and further developments in the use of various biomarkers along with the regular screening procedures. Hence, the enhanced accuracy and sensitivity of the screening tests is one of the crucial factors anticipated to propel growth in the coming years.
North America accounted for the maximum revenue share of 48.3% and is closely followed by Europe. The U.S. is the most important sector and captured the majority share of the North American segment. The growing prevalence of cervical cancer in the region and increasing awareness regarding early diagnosis can be attributed to the large share of the region.
Asia Pacific is expected to emerge as the fastest-growing region with a CAGR of 9.6% over the forecast period. Favourable government initiatives and increasing diagnostic rates are expected to drive the growth of the market in the region.
Key Players
Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Abbott Laboratories, OncoHealth Corp, Hologic, Inc., QIAGEN, Quest Diagnostics, Inc and Guided Therapeutics, Inc.
Market Segmentation
Test type outlook
-
Pap Testing
-
HPV Testing
-
Colposcopy
-
Cervical Biopsies
-
Cystoscopy
Regional outlook
-
North America
-
U.S.
-
Canada
-
-
Europe
-
UK
-
Germany
-
-
Asia Pacific
-
Japan
-
China
-
-
Latin America
-
Brazil
-
Mexico
-
-
Middle East and Africa
-
South Africa
-
The study objectives of this report are:
- To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
- Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
